Mostrar el registro sencillo

dc.contributor.authorMurillo García, Nancy
dc.contributor.authorSetién Suero, María Esther
dc.contributor.authorPardo-de-Santayana, Guillermo
dc.contributor.authorMurillo-García, Marisol
dc.contributor.authorPelayo Terán, José María
dc.contributor.authorCrespo Facorro, Benedicto 
dc.contributor.authorAyesa Arriola, Rosa 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2025-09-22T08:39:30Z
dc.date.available2025-09-22T08:39:30Z
dc.date.issued2021
dc.identifier.issn1751-7885
dc.identifier.issn1751-7893
dc.identifier.urihttps://hdl.handle.net/10902/37216
dc.description.abstractAim: To explore if the entire duration of active psychosis (DAP) is related to neurocognitive performance at baseline and at 3-year follow-up in patients with first episode psychosis (FEP). Methods: DAP was estimated for 481 FEP patients. A neuropsychological battery was administered to measure neurocognitive specific domains, and a global indicator of neurocognitive impairment (global deficits score, GDS) was calculated. According to the DAP quartiles, four subgroups were formed, and these were compared. In addition, a logistic regression analysis was carried out to predict neurocognitive impairment at 3-year follow-up. Results: FEP patients with the longest DAP (more than 18.36 months) presented a more severe global neurocognitive impairment evidenced in their GDS, both at baseline (F = 5.53; p< .01) and at 3-year follow-up (F = 4.16; p< .01). Moreover, a subgroup of participants with DAP between 7.40 and 18.36 months showed a specific attentional decline over the 3-year follow-up (F = 3.089; p< .05).The logistic regression model showed that sex (Wald = 7.29, p<.010), premorbid adjustment (Wald = 7.24, p<.010), attention (Wald = 12.10, p<.001), verbal memory (Wald = 16.29, p<.001) and visual memory (Wald = 9.41, p<.010) were significant predictors of neurocognitive impairment 3 years after the FEP. The variables composing the DAP were not significant predictors in this model. Conclusions: DAP seems to be related to global neurocognitive impairment in FEP patients. These findings contribute in several ways to our understanding of the effects of active psychosis on the brain, and provide the basis for future research.es_ES
dc.description.sponsorshipInstituto de Investigación Sanitaria Valdecilla y Universidad de Cantabria, Grant/Award Number: Predoctoral contract BOC49; REF. IDI-13; Nancy Mur; Instituto de Salud Carlos III, Grant/Award Number: Miguel Servet contract CP18/00003; Dr. Rosa Ayesa-Arriola
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rights© John Wiley & Sonses_ES
dc.sourceEarly Intervention in Psychiatry, 2021, 15(5), 1266-1275es_ES
dc.subject.otherCognitiones_ES
dc.subject.otherCognitive impairmentes_ES
dc.subject.otherNeuropsychologyes_ES
dc.subject.otherPsychosises_ES
dc.subject.otherPsychotic disorderses_ES
dc.titleEntire duration of active psychosis and neurocognitive performance in first-episode non-affective psychosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1111/eip.13077es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1111/eip.13077
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo